748P Prognostic factors related to post-platinum atezolizumab for relapsed metastatic urothelial cancer (mUC) from the SAUL studyA. Bamias,A. Merseburger,Y. Loriot,N. James,E. Choy,D. Castellano Gauna,F. Lopez-Rios,F. Calabro,M.W. Kramer,G. de Velasco,R. Zakopoulou,K. Tzannis,C.N. SternbergAnnals of Oncology(2020)引用 0|浏览15暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要